Cancer cells rarely begin stealthily. Quite the contrary, they alert the immune system to their presence by displaying chemical red flags on their membranes. When detected, the body's defences can swoop in and destroy renegade cells before they can do significant damage. Lipids, fatty molecu
The failure of the liver as a crucial organ is becoming more common due to fatty liver disease, often known as steatotic liver disease or SLD for short. Researchers have now found that a saturated fatty acid in blood vessels causes the synthesis of the signalling molecule SEMA3A, which shuts
Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting innate immunological pathways, today announced that the first patient was do
New Delhi [India], March 11: Best Agrolife Ltd (BAL) on Saturday announced the proposal to acquire Sudarshan Farm Chemicals India Pvt Ltd. (SFCL). SFCL is an established name in field of agrochemicals and innovative process chemistries having an IP portfolio of 10 patents (applied). This str
Israeli scientists established a crucial connection between Parkinson's disease and a network of molecules surrounding the brain, opening new avenues of research to better understand the disorder and develop targeted therapies.
Israeli scientists established a crucial connection between Parkinson's disease and a network of molecules surrounding the brain, opening new avenues of research to better understand the disorder and develop targeted therapies.
Israeli scientists unveiled research showcasing the potential of two small molecules to significantly mitigate the effects of Huntington's disease, offering hope for people afflicted with the disorder.
Researchers revealed that a rare sort of lipid plays a vital role in ferroptosis, a type of cell death described by Columbia professor Brent Stockwell.
Boston [US]/ Noida (Uttar Pradesh) [India], February 15: Curadev is excited to introduce CRD3874, a first-in-class allosteric small molecule STING agonist, with distinct pharmacological properties that distinguish it from agents that bind to STING's cGAMP site. An intravenous formulation of